You are here

Cancer Genetics Evaluation Program

The Cancer Genetics Evaluation Program was developed to help individuals and families with an increased risk of developing cancer based on a hereditary susceptibility. The program offers consultation to individuals who have already had cancer and are concerned about their risk for subsequent cancers, as well as unaffected individuals who are considered high risk. Genetic counselors, along with a team of oncology specialists, provide individualized family history analysis, risk evaluation and when possible, offer strategies for risk reduction.

This program is especially important if:

  • You or a biological relative have had cancer at an early age.
  • You or a biological relative have had more than one cancer or bilateral cancer.
  • You or a relative have had a rare or unusual cancer such as male breast cancer or adrenal gland cancer.
  • You have several biological relatives with cancer.
  • You have a relative with a known gene mutation in a gene that causes susceptibility to cancer (i.e. BRCA1, BRCA2, HNPCC, p53).
  • You have a family history of a known cancer syndrome such as Familial Polyposis, von Hippel-Lindau, Li-Fraumeni, Multiple Endocrine Neoplasia, Retinoblastoma.

Genetic testing is available in many situations to help clarify risk. However, not everyone who sees the genetic counselor will have a genetic test. Whether or not genetic testing is an option is discussed at the genetic counseling appointment. If, after genetic counseling, your risk is not considered to be any higher than that of an individual in the average population, genetic counseling can be reassuring. If your risk is increased, a surveillance program for early detection can be tailored to suit your needs, or cancer prevention strategies can be discussed, such as risk-reducing medications or surgeries.

Individuals who are not affected with cancer, but have a family history of breast, ovarian or gastrointestinal cancer and have never seen a member of the Loyola oncology team, may be seen in our Cancer Risk Assessment & Prevention Program.